Filing Details
- Accession Number:
- 0001213900-24-032295
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-11 20:30:07
- Reporting Period:
- 2024-04-09
- Accepted Time:
- 2024-04-11 20:30:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1769804 | Augmedix Inc. | AUGX | Services-Business Services, Nec (7389) | 833299164 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1826129 | Ian Shakil | C/O Augmedix, Inc. 111 Sutter Street, Suite 1300 San Francisco CA 94104 | Chief Strategy Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-04-09 | 14,356 | $0.64 | 17,356 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2024-04-09 | 17,186 | $0.86 | 34,542 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-04-09 | 31,542 | $4.14 | 3,000 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2024-04-10 | 36,467 | $0.86 | 39,467 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-04-10 | 36,467 | $3.87 | 3,000 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2024-04-11 | 24,778 | $0.86 | 27,778 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-04-11 | 24,778 | $3.93 | 3,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2024-04-09 | 14,356 | $0.00 | 14,356 | $0.64 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2024-04-09 | 17,186 | $0.00 | 17,186 | $0.86 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2024-04-10 | 36,467 | $0.00 | 36,467 | $0.86 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2024-04-11 | 24,778 | $0.00 | 24,778 | $0.86 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2030-06-03 | No | 4 | M | Direct | |
537,238 | 2028-12-05 | No | 4 | M | Direct | |
500,771 | 2028-12-05 | No | 4 | M | Direct | |
475,993 | 2028-12-05 | No | 4 | M | Direct |
Footnotes
- This transaction was executed pursuant to a Rule 10b5-1 trading plan.
- This transaction was executed in multiple trades ranging from $4.0600 to $4.2400. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This transaction was executed in multiple trades ranging from $3.8000 to $4.0400. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- This transaction was executed in multiple trades ranging from $3.8200 to $4.0000. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- Fully vested.